ArticleCost effectiveness and resource allocation : C/E2007

Cost-effectiveness of tipranavir versus comparator protease inhibitor regimens in HIV infected patients previously exposed to antiretroviral therapy in the Netherlands.

Gijs A A Hubben et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.